Exhale

The official blog of the Lung Institute.

What Inhalers Are Used for COPD?

22 Aug 2017
| Under COPD | Posted by | 2 Comments
What Inhalers Are Used for COPD?

Inhalers are a mainstay of chronic obstructive pulmonary disease (COPD) treatment. These portable medical devices are designed to hold medications that are administered through inhalation (breathing in). Inhalers are particularly useful for treating lung conditions because inhaled medications can reach the airways without traveling throughout the rest of the body.

Several types of inhaled medications can be used in an inhaler. The most commonly prescribed medication for COPD is a bronchodilator, which can relax the muscles surrounding the airways, reduce inflammation and promote air flow. Some bronchodilators are effective right away, while others take some time to produce meaningful results.

Three main types of inhaler devices are used to deliver medications for the treatment of COPD:

  • Hydrofluoroalkane (HFA) inhalers – Also known as metered dose inhalers (MDIs), these handheld canisters contain a pressurized, inactive gas that propels a precise dosage of liquid medication whenever the top of the device is pressed.
  • Dry powder inhalers (DPIs) – Operating in a manner similar to HFA inhalers, DPIs release a puff of dry powder instead of a liquid mist.
  • Soft mist inhalers (SMIs) – A premeasured amount of medicine is delivered in a slow-moving mist regardless of how fast air is inhaled from the device.

While the treatment goal is the same, each type of COPD inhaler works differently. For instance, an HFA inhaler should be shaken prior to use, but a DPI should never be agitated. Therefore, it’s important to understand how to properly use a specific inhaler in order to maximize the effectiveness of COPD treatment.

Some people are initially able to manage their COPD symptoms with inhalers and other treatments, but as the condition progresses, it can significantly diminish both lung function and quality of life. At the Lung Institute, we offer stem cell therapy, which is unique in that it has the potential to actually slow the progression of COPD. Our stem cell therapies are provided on an outpatient basis, allowing our patients to return to the comfort of their own homes shortly after treatment.

To find out if stem cell therapy is right for you, contact the Lung Institute at (800) 729-3065 to schedule a free consultation.

2 Comments

  1. Lung Institute

    3 weeks ago

    Jean:

    Thank you for your message. While we do not have any clinics in the midwest right now, we do have some not too far away. It’s best to speak one-on-one with one of our patient coordinators. They have a wealth of knowledge about stem cells, treatment options, candidacy, cost and even lodging. Feel free to contact us at (855) 313-1149. We look forward to speaking with you soon.

    Kind regards,

    The Lung Institute

    CLINIC LOCATIONS
    Tampa
    (813) 642-6417

    Nashville
    (615) 988-1051

    Dallas
    (214) 935-1699

    Scottsdale
    (480) 378-6658

    Pittsburgh
    (724) 635-4202

  2. Jean Schirf

    4 weeks ago

    I guess I will have to wait until you get a clinic in the Midwest. I hope I live long enough to at least try the stem cell . I’m 70 with COPD , my oxygen level is still good but I have a lot of mucus. Ive not smoked for close to a year before that I bought a pack of cigs once a week & weaned myself off ….SO that’s making it better for me. Thank God I. I’m expecting a new grandson Jan 1st….

Your Comment

Your email address will not be published.



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.